{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:43:05Z","timestamp":1784734985555,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001785","name":"Flinders University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.pathol.2024.02.016","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T01:47:57Z","timestamp":1715219277000},"page":"662-670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The significance of BAP1 and MTAP\/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1596-2774","authenticated-orcid":false,"given":"Aniza","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3252-2519","authenticated-orcid":false,"given":"Sarita","family":"Prabhakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Pulford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashleigh J.","family":"Hocking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Godbolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8540-8977","authenticated-orcid":false,"given":"Fouzia","family":"Ziad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4258-8087","authenticated-orcid":false,"given":"Archana","family":"Pandita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3460-6955","authenticated-orcid":false,"given":"Annesu","family":"Wessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hussey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5703-9414","authenticated-orcid":false,"given":"Prudence A.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8976-4714","authenticated-orcid":false,"given":"Sonja","family":"Klebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2024.02.016_bib1","series-title":"WHO Classification of Tumours. Thoracic Tumours","year":"2021"},{"key":"10.1016\/j.pathol.2024.02.016_bib2","series-title":"WHO Classification of Tumours Editorial Board. WHO Classification of Tumours. Thoracic Tumours","article-title":"Well-differentiated papillary mesothelial tumour","author":"Quick","year":"2021"},{"key":"10.1016\/j.pathol.2024.02.016_bib3","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/PAS.0000000000000200","article-title":"Well-differentiated papillary mesothelioma with invasive foci","volume":"38","author":"Churg","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2024.02.016_bib4","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/00000478-200110000-00012","article-title":"Well-differentiated papillary mesothelioma","volume":"25","author":"Butnor","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2024.02.016_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/PAS.0b013e3182354a79","article-title":"Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases","volume":"36","author":"Malpica","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2024.02.016_bib6","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1245\/s10434-018-07153-2","article-title":"Well-differentiated papillary mesothelioma of the peritoneum: a retrospective study from the RENAPE Observational Registry","volume":"26","author":"Vogin","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.pathol.2024.02.016_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.anndiagpath.2018.10.012","article-title":"Well-differentiated papillary mesothelioma: a 17-year single institution experience with a series of 75 cases","volume":"38","author":"Sun","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.pathol.2024.02.016_bib8","series-title":"WHO Classification of Tumours Editorial Board. WHO Classification of Tumours. Thoracic Tumours","article-title":"Mesothelioma in situ","author":"Dacic","year":"2021"},{"key":"10.1016\/j.pathol.2024.02.016_bib9","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41379-022-01082-y","article-title":"Well differentiated papillary mesothelial tumor: a new name and new problems","volume":"35","author":"Churg","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2024.02.016_bib10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/1097-0142(19900115)65:2<292::AID-CNCR2820650218>3.0.CO;2-W","article-title":"Well-differentiated papillary mesothelioma of the peritoneum. A clinicopathologic study of 22 cases","volume":"65","author":"Daya","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2024.02.016_bib11","first-page":"633","article-title":"Clinicopathological characteristics of well-differentiated papillary mesothelioma of the peritoneum: a single-institutional experience of 12 Cases","volume":"33","author":"Kim","year":"2019","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.pathol.2024.02.016_bib12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/00000478-200404000-00013","article-title":"Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases","volume":"28","author":"Galateau-Salle","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2024.02.016_bib13","first-page":"220","article-title":"Well-differentiated papillary mesothelial tumor: an unusual radiologic presentation: a case report","volume":"56","author":"Abdelghafar","year":"2023","journal-title":"J\u00a0Chest Surg"},{"key":"10.1016\/j.pathol.2024.02.016_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.humpath.2017.10.036","article-title":"Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study","volume":"72","author":"Xing","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2024.02.016_bib15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/PAS.0000000000002033","article-title":"Mesothelioma in situ mimicking well-differentiated papillary mesothelial tumor","volume":"47","author":"Galateau-Salle","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2024.02.016_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/carcin\/bgu227","article-title":"Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival","volume":"36","author":"Baumann","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pathol.2024.02.016_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5858\/arpa.2017-0092-OA","article-title":"Immunohistochemistry in peritoneal mesothelioma: a single-center experience of 244 cases","volume":"142","author":"Tandon","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2024.02.016_bib18","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","article-title":"Biological mechanisms and clinical significance of BAP1 mutations in human cancer","volume":"10","author":"Carbone","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.pathol.2024.02.016_bib19","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.21037\/tlcr.2019.11.29","article-title":"Application of immunohistochemistry in diagnosis and management of malignant mesothelioma","volume":"9","author":"Chapel","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.pathol.2024.02.016_bib20","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2024.02.016_bib21","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/jnci\/djy171","article-title":"Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide","volume":"110","author":"Walpole","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.pathol.2024.02.016_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/gcc.22670","article-title":"Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes","volume":"57","author":"Betti","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.pathol.2024.02.016_bib23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/pin.12453","article-title":"BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests","volume":"66","author":"Hida","year":"2016","journal-title":"Pathol Int"},{"key":"10.1016\/j.pathol.2024.02.016_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.anndiagpath.2016.10.010","article-title":"Usefulness of p16\/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the\u00a0diagnosis of biphasic mesothelioma","volume":"26","author":"Wu","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.pathol.2024.02.016_bib25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lungcan.2016.12.017","article-title":"Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: comparison with 9p21 FISH and BAP1 immunohistochemistry","volume":"104","author":"Hida","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.pathol.2024.02.016_bib26","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.5858\/arpa.2018-0273-OA","article-title":"Utility of methylthioadenosine phosphorylase compared with BAP1 immunohistochemistry, and CDKN2A and NF2 fluorescence in situ hybridization in separating reactive mesothelial proliferations from epithelioid malignant mesotheliomas","volume":"142","author":"Berg","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2024.02.016_bib27","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/s41379-022-01081-z","article-title":"Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry\u00a0in\u00a0diagnosis of pleural mesothelioma","volume":"35","author":"Chapel","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2024.02.016_bib28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.humpath.2018.05.001","article-title":"BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma","volume":"79","author":"Lee","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2024.02.016_bib29","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3390\/cancers12061568","article-title":"Well-differentiated papillary mesothelioma of the peritoneum is genetically distinct from malignant mesothelioma","volume":"12","author":"Shrestha","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.pathol.2024.02.016_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41379-018-0127-2","article-title":"Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42","volume":"32","author":"Stevers","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2024.02.016_bib31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2024.02.016_bib32","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.cancergen.2012.08.005","article-title":"Heterozygous loss of NF2 is an early molecular alteration in well-differentiated papillary mesothelioma of the peritoneum","volume":"205","author":"Nemoto","year":"2012","journal-title":"Cancer Genet"},{"key":"10.1016\/j.pathol.2024.02.016_bib33","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/annonc\/mdt135","article-title":"Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation","volume":"24","author":"Ribeiro","year":"2013","journal-title":"Ann Oncol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302524001272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302524001272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T20:52:45Z","timestamp":1720126365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302524001272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0031302524001272"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2024.02.016","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The significance of BAP1 and MTAP\/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2024.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia.","name":"copyright","label":"Copyright"}]}}